Tigenix: latest news - GoINPHARMA
Friday, 16 November 2018 - 8:39


First large acquisition of the year: Takeda acquires Tigenix for €520m

Belgian-Spanish biotech company TiGenix NV and Takeda Pharmaceutical have jointly announced today, before trading opened, that Takeda is planning to purchase all TiGenix shares at €1.79 per share, which means setting TiGenix’s value at approximately €520m. TiGenix’s key asset is…